IDDM: an islet or an immune disease?

Diabetologia

Volumn 37, Issue 2 Supplement, 1994, Pages

  Boitard, C ^a   Larger, E ^b   Timsit, J ^a   Sempe, P ^a   Bach, J F ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

animal models; autoantibodies; autoantigens; autoimmunity; Diabetes mellitus; T cells

Indexed keywords

ALLOXAN; AUTOANTIBODY; AUTOANTIGEN; CYCLOSPORIN; INTERLEUKIN 2;

ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AWARDS AND PRIZES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; ENVIRONMENT; EUROPE; FRANCE; HISTORY, 20TH CENTURY; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MALE; PORTRAITS; SOCIETIES, MEDICAL; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 0028023996     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00400831     Document Type: Article

References (107)

1. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies
2. Insulin antibodies in insulin-dependent diabetics before insulin treatment
3. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
4. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes
5. Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products
6. Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment
7. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen
8. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus
9. Insulin-dependent diabetes: a disease of autoaggression
10. In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon
11. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes
12. Human T cell clones with specificity for insulinoma cell antigens
13. T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins
14. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes
15. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
16. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
17. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes
18. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
19. Both the Lyt-2 + and L3T4 + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice
20. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4 + and Lyt-2 + T cells
21. Passive transfer of diabetes in the BB/W rat
22. Pancreatic islet-specific T-cell clones from nonobese diabetic mice
23. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone
24. Presentation of beta-cell antigens to CD4 + and CD8 + T cells of nonobese diabetic mice
25. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice
26. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma
27. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases
28. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis
29. In vivo expression of perform by CD8 + lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in nonobese diabetic mice
30. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice
31. CD8 T cells are not required for islet destruction induced by a CD4 + islet-specific T-cell clone
32. Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat
33. The role of CD4 + and CD8 + T cells in the destruction of islet grafts by spontaneously diabetic mice
34. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes
35. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans
36. The specificity of rejection and the absence of susceptibility of pancreatic islet beta cells to nonspecific immune destruction in mixed strain islets grafted beneath the renal capsule in the rat
37. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1
38. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice
39. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes
40. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas
41. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
42. The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects
43. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice
44. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response
45. Polygenic control of autoimmune diabetes in nonobese diabetic mice
46. Pancreatic beta cell heterogeneity in glucose-induced insulin secretion
47. Dietary prevention of diabetes in the non-obese diabetic mouse
48. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence
49. Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus
50. Dietary protein: a trigger of insulin-dependent diabetes in the BB rat?
51. Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes
52. Inhibition of diabetes in BB rats by virus infection
53. Androgen treatment prevents diabetes in nonobese diabetic mice
54. Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse
55. Poly I:C induces development of diabetes mellitus in BB rat
56. Induction of type I diabetes by Kilham's rat virus in diabetesresistant BB/Wor rats
57. Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens
58. Superantigen-like effects and incidence of diabetes in NOD mice
59. Induction of islet cell surface and insulin antibodies in Balb/c mice by application of porcine insulin and Freund's adjuvant is not associated with insulitis
60. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein
61. Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression
62. Role of viruses in the pathogenesis of IDDM
63. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus
64. Immunologic studies on the induction of diabetes in experimental animals. Cellular basis for the induction of diabetes by streptozotocin
65. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes
66. Treatment with anti-T-lymphocyte antibodies prevents induction of insulitis in mice given multiple doses of streptozocin
67. Prevention of autoimmune diabetes with nonactivating antiCD3 monoclonal antibody
68. Multiple low dose streptozotocin induces systemic MHC expression in mice by triggering T cells to release IFN-gamma
69. IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse
70. Induction of tolerance to autoimmune diabetes with islet antigens
71. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
72. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity
73. A transgenic model of autoimmune hemolytic anemia
74. Failed selftolerance and autoimmunity in IgG anti-DNA transgenic mice
75. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
76. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane
77. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice
78. Autoimmune diabetes as a consequence of locally produced interleukin-2
79. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats
80. Depletion of RT6.1 + T lymphocytes induces diabetes in resistant biobreeding/Worcester (BBAV) rats
81. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
82. Adoptive immunotherapy of diabetes in autologous nonobese diabetic mice with lymphoid cells ex vivo exposed to cyclosporin plus interleukin 2
83. Curtailment of autoimmunity following parabiosis with a normal partner
84. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4 + T cell subset that inhibits this autoimmune potential
85. IDDM in rats induced by thymectomy and irradiation
86. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis
87. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes
88. Role of CD4 +CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse
89. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity
90. B-cell responses in autoimmune diseases
91. Autoantibodies in pathology and cell biology
92. Ig V kappa family repertoire of plasma cells derived from autoimmune MRL mice
93. The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis
94. Uptake and metabolism of iodine is crucial for the development of thyroiditis in obese strain chickens
95. The role of self-antigen in the development of autoimmunity in obese strain chickens with spontaneous autoallergic thyroiditis
96. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy
97. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals
98. Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats
99. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse
100. Prevention of adoptive transfer in BB rats by prophylactic insulin treatment
101. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus
102. Insulin prophylaxis in individuals at high risk of type I diabetes
103. The insulin receptor on activated immunocompetent cells
104. Reduction of diabetes incidence in NOD mice by neonatal glucose treatment
105. Prevention of the incidence of diabetes by dietary sorbose in nonobese diabetic mice
106. Prevention of diabetes mellitus in BB rats by neonatal stimulation of beta cells
107. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells